Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,832 total articles
Amprius Technologies offers one of the clearest risk/reward setups in battery microcaps: proprietary silicon-nanowire cells that solve energy-density limits for tactical drones, a defense procurement cycle (NDAA) favoring domestic suppliers, and a market cap of roughly $1.34B. The upside is large if Amprius becomes the incumbent NDAA-compliant supp…
Meta Platforms (META) is a pragmatic way to own AI exposure inside a cash-generative social-media franchise. At $650.64 shares, the stock trades at ~27x earnings with a $1.645 trillion market cap, attractive cash flow and meaningful upside to recent highs. This trade idea lays out a long entry, stop and target for a 180-trading-day horizon while ba…
Coinbase is a profitable, cash-generative crypto exchange whose share price has been hammered by crypto weakness. Technicals show oversold conditions, valuation metrics are reasonable for a high-quality, cyclical growth business, and short-covering can amplify an upside. This is a structured mid-term (45 trading days) long trade: entry at $166.71, …
Oscar Health (OSCR) is coming off a rough 2025 driven by higher medical costs and morbidity, but management's 2026 guidance - $18.7-19B revenue and $250-450M in operating earnings - plus membership growth to 2.04M creates a scenario for meaningful price discovery. This trade idea lays out a long, high-conviction position sized for volatility: entry…
NatWest (NWG) tumbled after the £2.7bn Evelyn Partners acquisition announcement but the deal — plus a £750m buyback and clear cost-synergy targets — leaves the stock cheap on classic bank metrics. Technicals show short-term oversold conditions. This is a mid-term (45 trading days) trade idea: accumulate at the dip with a defined stop and two-stage …
Palantir is executing: high revenue growth, expanding cash flow and sticky government/commercial contracts. Valuation is extreme (P/E ~205x, market cap >$300B) and the stock is sensitive to AI-cycle sentiment. Trade plan: initiate a small long at $128.00, protect with a $100.00 stop, take first profits at $180.00 and consider doubling down on a dee…
Par Pacific (PARR) is a cash-generative, niche refiner with a durable advantage in distillates for Hawaii and parts of the U.S. West. With a market cap near $2.13B, EV/EBITDA ~5.6x and free cash flow of roughly $167M, the stock looks reasonably priced. I recommend a mid-term long (45 trading days) to capture a potential re-rating if refinery throug…
DoorDash is trading well below its moving averages and 52-week high despite positive operational momentum: $2.29B in free cash flow, modest leverage and expanding retail partnerships. Technical indicators are deeply oversold, presenting a high-probability rebound trade. Reiterate Buy with a clear entry, stop and target for a swing (45 trading days)…
Zillow fell to a 52-week low on weak Q1 guidance and headlines about AI competition and lawsuits. The sell-off overshoots the real business risk. With a $10.5B market cap, $1.13B in cash, low debt and $235M in free cash flow, Zillow can absorb short-term legal noise and iterate products. I recommend a long entry on the plunge with a clear stop and …
FormFactor (FORM) has moved from recovery to expansion: recent beats, a string of strategic moves into photonics and advanced manufacturing, and clear DRAM/HBM tailwinds are combining to lift revenue mix and gross margins. The trade: initiate a long at $96.50 with a disciplined stop and a mid-term target of $120 tied to continued HBM traction and m…
Atlanta Braves Holdings offers exposure to one of MLB's strongest franchises plus adjacent real estate cash flows at a market cap of roughly $2.9B. Balance-sheet leverage and negative FCF justify caution, but limited public float, franchise moat and mixed-use real estate underappreciation create a defined asymmetric trade. Enter at $46.00, stop $41…
TKO Group is increasingly a cash-flow story. After a string of rights monetization wins and a dividend bump plus buyback activity, the business prints meaningful free cash flow ($979M) and trades at attractive enterprise multiples (EV/EBITDA 12.8) relative to its growth optionality. This trade idea targets a measured long into that cash conversion …
Adobe has been slammed with the broader software sell-off tied to AI fears, but the company still generates nearly $10B in free cash flow, posts extremely high returns on capital, and trades at a single-digit-ish free cash flow multiple. This idea lays out a mid-term swing trade: entry at the current price, a clear stop under the recent low, and a …
Nebius (NBIS) is positioned at the center of the AI compute buildout. A credible jump in annual run-rate to the low billions by year-end and improving GPU-as-a-Service economics create a pathway to $180/share. This trade idea lays out an entry, stop, and targets with a long-term (180 trading days) horizon while calling out execution, margin, and ma…
Qfin (QFIN) looks like a classic, messy value opportunity: profitable with a low P/E (2.3), a sub-1x PB, and a 9%+ dividend yield, yet the stock trades near its 52-week low. The business is an AI-empowered credit-tech provider in China with recurring service revenue and sizable earnings implied by the current market cap. This trade idea lays out a …
Viking Therapeutics (VKTX) is a clinical-stage biotech with a GLP-1/GIP-weight loss candidate, VK2735, edging toward a commercial inflection. With the stock trading around $30.75 after a volatile session, elevated short interest and above-average volume suggest institution-level accumulation. This trade idea lays out an entry at $30.75, a stop at $…
MP Materials (MP) is trading well off its 52-week high after a pullback in rare-earth sentiment. The company has a tangible government cushion - a $400M DoD investment and a 10-year magnet supply agreement with a $110/kg price floor - that provides a policy-backed cash-flow floor. This trade targets a recovery toward $85 driven by contract-driven r…
MSCI announced a 13.9% dividend increase with ex-dividend on 02/13/2026 while continuing to deliver double-digit revenue and EPS growth. The stock is trading near $522 with technicals showing short-term oversold conditions; we outline a mid-term swing trade that captures upside to $600 while limiting downside with a $490 stop.
Microsoft's mix of cloud scale, strong free cash flow and favorable AI positioning make it an attractive buy after a pullback tied to headlines around OpenAI's valuation. The company trades at ~25x earnings with $77B of free cash flow and a $2.98T market cap. Technicals look oversold while macro AI capex remains a tailwind. Trade plan included for …
Tuya is a rare combination in the small-cap tech bucket: reported profitability (P/E ~27), platform-scale AI interactions, and a market cap of roughly $1.34B. The market prices the stock like a cyclical IoT vendor; we see a reasonable asymmetric upside over the next 45 trading days if product monetization and adoption signals continue to improve.
Crocs reported a solid Q4 and remains underappreciated by the market. At roughly $98.46, the stock trades at about a $5.1B market cap with free cash flow of $716M, implying a FCF yield in the low double-digits and an EV/EBITDA of ~6.2. That combination of strong cash conversion, brand strength, and buyback optionality makes CROX an actionable long …
Gray Media owns the largest portfolio of local TV stations in the U.S., and its expanding Spanish-language footprint plus upcoming sports and political programming create a clear revenue lever for 2026. Valuation metrics look cheap at the equity level, but leverage is high. This trade targets a re-rating into the mid-$6s as political and sports ad …
REGENXBIO (RGNX) is a clinical-stage AAV gene therapy company that traded lower after the FDA placed clinical holds on RGX-111 and RGX-121 following a reported neoplasm case. At $8.33 and a market cap near $422M, the stock appears to price in meaningful program risk. I am cautiously bullish: enter a staged long with tight risk control and a target …
Innovative Solutions & Support reported continuing double-digit growth driven by F-16 product integration and aftermarket demand. Market reaction has been muted by timing effects and legal headlines, creating a tradeable pullback. I lay out a mid-term swing entry, stop and target with the rationale, catalysts and balanced risk framing.
Chipotle (CMG) looks neither deeply undervalued nor richly expensive. The shares trade near $35.84 with a ~30-31x P/E and strong return metrics, but 2025 traffic weakness and margin trade-offs in 2026 mean upside depends on re-accelerating visits. A measured, mid-term buy-on-weakness approach with a defined stop and target captures upside if traffi…
